Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence

被引:1
|
作者
Won, Ho-Ryun [1 ,2 ]
Kim, Min Gyu [1 ]
Kim, Min Soo [1 ]
Chang, Jae Won [1 ,3 ]
Koo, Bon Seok [1 ,3 ]
机构
[1] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Daejeon, South Korea
[2] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Sejong Hosp, Sejong, South Korea
[3] Chungnam Natl Univ Hosp, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea
基金
新加坡国家研究基金会;
关键词
thyroid cancer; papillary thyroid microcarcinoma; active surveillance; recurrence; clinical factor; BRAF MUTATION; CANCER; ASSOCIATION; CARCINOMA;
D O I
10.1530/ETJ-23-0195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Active surveillance (AS) has been suggested as a management option for low-risk papillary thyroid microcarcinoma (PTMC). However, the currently proposed selection criteria for AS application do not consider various clinical factors. The purpose of this study was to analyze clinical factors related to recurrence that could be confirmed preoperatively in patients who underwent surgery for PTMC and to identify factors worth considering when deciding whether to apply AS. Materials and methods: Data were collected from patients with PTMC who underwent surgical treatment at Chungnam National University Hospital. A retrospective cohort was established according to the presence or absence of recurrence during the follow-up period. In total, 2717 patients were enrolled, of whom 60 experienced recurrence. Various clinical factors that could be identified before surgery were analyzed. Results: The relationship between various clinical factors that could be confirmed preoperatively and recurrence was confirmed through Cox regression analysis and Kaplan-Meier curve analysis. BRAF mutation and the tall cell variant were significantly more common in patients with recurrence. In patients aged 55 years or older, the risk of recurrence was lower than in younger patients, while the recurrence-free survival (RFS) rate was higher. Conclusion: When choosing between surgical treatment or AS in PTMC patients, additional consideration of the patient's clinical factors, such as age and BRAF mutation status, may be required in addition to the existing criteria.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Patients' View on the Management of Papillary Thyroid Microcarcinoma: Active Surveillance or Surgery
    Yoshida, Yusaku
    Horiuchi, Kiyomi
    Okamoto, Takahiro
    THYROID, 2020, 30 (05) : 681 - 687
  • [2] Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects
    Xue, Shuai
    Wang, Peisong
    Hurst, Zachary A.
    Chang, Yi Seok
    Chen, Guang
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [3] Papillary thyroid microcarcinoma: Is active surveillance always enough?
    Sutherland, Rosie
    Tsang, Venessa
    Clifton-Bligh, Roderick J.
    Gild, Matti L.
    CLINICAL ENDOCRINOLOGY, 2021, 95 (06) : 811 - 817
  • [4] Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid
    Miyauchi, Akira
    WORLD JOURNAL OF SURGERY, 2016, 40 (03) : 516 - 522
  • [5] Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid
    Akira Miyauchi
    World Journal of Surgery, 2016, 40 : 516 - 522
  • [6] Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma
    Luo, Y.
    Zhao, Y.
    Chen, K.
    Shen, J.
    Shi, J.
    Lu, S.
    Lei, J.
    Li, Z.
    Luo, D.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (02) : 227 - 236
  • [7] Active surveillance of low-risk papillary thyroid microcarcinoma
    Sugitani, Iwao
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (01)
  • [8] Risk factors of papillary thyroid microcarcinoma that predispose patients to local recurrence
    Kaliszewski, Krzysztof
    Diakowska, Dorota
    Rzeszutko, Marta
    Nowak, Lukasz
    Aporowicz, Michal
    Wojtczak, Beata
    Sutkowski, Krzysztof
    Rudnicki, Jerzy
    PLOS ONE, 2020, 15 (12):
  • [9] Active Surveillance of Papillary Thyroid Microcarcinoma: Where Do We Stand?
    Jeon, Min Ji
    Kim, Won Gu
    Chung, Ki-Wook
    Baek, Jung Hwan
    Kim, Won Bae
    Shong, Young Kee
    EUROPEAN THYROID JOURNAL, 2019, 8 (06) : 298 - 306
  • [10] Active surveillance in papillary thyroid microcarcinoma
    Lamartina, L.
    Leboulleux, S.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2019, 23 (4-5): : 116 - 118